Humana Inc. (HUM) director discloses deferred restricted stock unit awards

Rhea-AI Filing Summary

Humana Inc. director John W. Garratt reported equity awards and his updated holdings. On 12/31/2025, he acquired 16 restricted stock units tied to dividend payments, and on 01/02/2026 he acquired 766 restricted stock units as part of his annual director fee. These stock units are deferred until he resigns as a director, when they will be settled in Humana common stock on a 1-for-1 basis under the company’s 2019 Amended & Restated Plan.

Following these transactions, he directly beneficially owns 1,685 shares of Humana common stock. He also beneficially owns 1,929 restricted stock units described in note (1) and 18 restricted stock units described in note (2) as derivative securities, each corresponding to one share of Humana common stock upon settlement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garratt John W

(Last) (First) (Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE KY 40202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common								1,685	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	(1)	01/02/2026		A		766		(1)	(1)	Humana Common	766	$0	1,929(1)	D
Restricted Stock Units(2)	(2)	12/31/2025		A		16		(2)	(2)	Humana Common	16	$258.8675	18	D

Explanation of Responses:

1. Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

2. Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

	John W. Garratt	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Humana (HUM) director John W. Garratt report?

John W. Garratt reported the acquisition of restricted stock units related to his compensation as a director and dividend reinvestment, along with his updated Humana common stock and stock unit holdings.

How many restricted stock units did the Humana (HUM) director receive as an annual fee?

On 01/02/2026, John W. Garratt received 766 restricted stock units as part of his annual director’s fee, to be settled in Humana Inc. common stock on a 1-for-1 basis upon his resignation as a director.

What dividend-related stock units did the Humana (HUM) director report?

On 12/31/2025, he reported 16 restricted stock units from dividend payments reinvested into stock units on vested and deferred stock units, which will also be payable in Humana common stock on a 1-for-1 basis after his service as a director ends.

How many Humana (HUM) common shares does the director own after these transactions?

After the reported transactions, John W. Garratt directly beneficially owns 1,685 shares of Humana Inc. common stock.

What are the director’s total restricted stock unit holdings in Humana (HUM)?

Following the transactions, he beneficially owns 1,929 restricted stock units referenced in note (1) and 18 restricted stock units referenced in note (2), each representing a contingent right to receive one share of Humana Inc. common stock.

When will the Humana (HUM) director receive shares from these stock units?

The stock units have been deferred until his resignation as a director, at which time the units and deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, in accordance with the company’s plan.